Skip to Main Content

Anne Wojcicki

CEO and co-founder, 23andMe

Wojcicki co-founded 23andMe 16 years ago, and although the company is best known for its low-cost consumer genetic testing service, it works on a variety of health care and biotechnology fronts. A test for prostate cancer risk won FDA clearance this January. 23andMe has recently launched, in partnership with GSK, a clinical trial for an immunotherapy drug. And in 2021 Wojcicki led 23andMe through an IPO that raised $592 million after the company merged with a special-purpose acquisition corporation backed by billionaire Richard Branson.

From STAT:



  • 48


  • Mountain View, CA


The definitive list of authoritative leaders and influencers in health and life science

View the List